Published in J Urol on October 24, 2012
Evaluation of voiding assays in mice: impact of genetic strains and sex. Am J Physiol Renal Physiol (2015) 1.48
Role of urodynamics before prolapse surgery. Int Urogynecol J (2014) 1.39
Expectations of stress urinary incontinence surgery in patients with mixed urinary incontinence. Rev Urol (2015) 1.39
Effective and organ specific radiation doses from videourodynamics in children. J Urol (2013) 1.39
CUA guideline on adult overactive bladder. Can Urol Assoc J (2017) 1.08
Acupuncture for adults with overactive bladder: a systematic review protocol. BMJ Open (2015) 0.97
Female pelvic medicine and reconstructive surgery practice patterns: IUGA member survey. Int Urogynecol J (2015) 0.92
The effect of posture and repetition on urodynamic parameters: A prospective randomized study. Investig Clin Urol (2017) 0.82
The cost of preoperative urodynamics: A secondary analysis of the ValUE trial. Neurourol Urodyn (2014) 0.82
Maintenance of the therapeutic effect of two high-dosage antimuscarinics in the management of overactive bladder in elderly women. Int Neurourol J (2013) 0.78
Trends and Patterns of Urodynamic Studies in U.S. Males, 2000-2012. PLoS One (2015) 0.78
Electroacupuncture at points Baliao and Huiyang (BL35) for post-stroke detrusor overactivity. Neural Regen Res (2013) 0.78
A pilot study to measure dynamic elasticity of the bladder during urodynamics. Neurourol Urodyn (2016) 0.77
Effectiveness of mesh compared with nonmesh sling surgery in Medicare beneficiaries. Obstet Gynecol (2013) 0.75
The evidence for urodynamic investigation of patients with symptoms of urinary incontinence. F1000Prime Rep (2013) 0.75
The Worldwide Economic Impact of Neurogenic Bladder. Curr Bladder Dysfunct Rep (2015) 0.75
The Value of Urodynamics in an Academic Specialty Referral Practice. Urology (2017) 0.75
Not all neurogenic bladders are the same: a proposal for a new neurogenic bladder classification system. Transl Androl Urol (2016) 0.75
Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis. Sci Rep (2016) 0.75
De novo stress urinary incontinence after pelvic organ prolapse surgery in women without occult incontinence. Int Urogynecol J (2016) 0.75
Incidence and Management of Lower Urinary Tract Symptoms After Urethral Stricture Repair. Curr Urol Rep (2017) 0.75
Follow-up urodynamics in patients with neurogenic bladder. Indian J Urol (2017) 0.75
Low amplitude rhythmic contraction frequency in human detrusor strips correlates with phasic intravesical pressure waves. World J Urol (2016) 0.75
Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med (2010) 7.95
Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med (2007) 7.90
Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73
Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol (2008) 4.90
A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med (2012) 4.59
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA (2006) 4.15
The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med (2006) 3.93
American Urological Association guideline on the management of priapism. J Urol (2003) 3.77
Time to rethink: an evidence-based response from pelvic surgeons to the FDA Safety Communication: "UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse". Int Urogynecol J (2011) 3.62
An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol (2003) 3.21
Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev (2004) 3.08
AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol (2011) 3.00
Purely transvaginal/perineal management of complications from commercial prolapse kits using a new prostheses/grafts complication classification system. J Urol (2012) 2.98
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol (2012) 2.96
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc (2003) 2.75
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol (2010) 2.68
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int (2009) 2.63
Artificial urinary sphincter revision: the role of ultrasound. Urology (2013) 2.62
Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology (2006) 2.59
Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol (2008) 2.57
Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol (2010) 2.43
Urodynamic measures do not predict stress continence outcomes after surgery for stress urinary incontinence in selected women. J Urol (2008) 2.43
Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries. Neurourol Urodyn (2012) 2.35
Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab (2010) 2.28
Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol (2011) 2.09
Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology (2007) 2.09
Management of iatrogenic foreign bodies of the bladder and urethra following pelvic floor surgery. Neurourol Urodyn (2008) 2.08
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol (2009) 2.06
Contemporary management of postprostatectomy incontinence. Eur Urol (2011) 2.01
The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int (2009) 2.00
Patient-reported reasons for discontinuing overactive bladder medication. BJU Int (2009) 1.94
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol (2006) 1.94
Social networks lack useful content for incontinence. Urology (2011) 1.89
The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol (2010) 1.86
Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol (2012) 1.85
Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol (2013) 1.83
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. Eur Urol (2012) 1.81
A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol (2009) 1.76
High rate of vaginal erosions associated with the mentor ObTape. J Urol (2006) 1.76
An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol (2003) 1.73
Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Urology (2011) 1.70
Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial. Ann Intern Med (2008) 1.68
Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach. J Urol (2008) 1.67
Urodynamics, the supine empty bladder stress test, and incontinence severity. Neurourol Urodyn (2010) 1.66
Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer. J Urol (2006) 1.64
The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery. J Urol (2012) 1.64
Vesicovaginal fistula and mesh erosion after Perigee (transobturator polypropylene mesh anterior repair). Urology (2006) 1.63
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011. Neurourol Urodyn (2012) 1.56
Refining diagnosis of anatomic female bladder outlet obstruction: comparison of pressure-flow study parameters in clinically obstructed women with those of normal controls. Urology (2004) 1.55
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Risk of infection after midurethral synthetic sling surgery: are postoperative antibiotics necessary? Urology (2010) 1.55
Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn (2010) 1.55
Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits. Am J Physiol Regul Integr Comp Physiol (2004) 1.55
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol (2005) 1.54
Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol (2011) 1.54
Incidence of perioperative urinary tract infection after single-dose antibiotic therapy for midurethal slings. Urology (2010) 1.53
The "costs" of urinary incontinence for women. Obstet Gynecol (2006) 1.52
The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU Int (2013) 1.52
Transvaginal hybrid natural orifice transluminal surgery robotic donor nephrectomy: first clinical application. Urology (2012) 1.51
Large-conductance voltage- and Ca2+-activated K+ channels regulate human detrusor smooth muscle function. Am J Physiol Cell Physiol (2011) 1.50
A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol (2005) 1.49
Pre-operative urodynamics in women with stress urinary incontinence increases physician confidence, but does not improve outcomes. Neurourol Urodyn (2013) 1.49
Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol (2005) 1.49
Prolapse of a single-system ureterocele causing urinary retention in an adult woman. Int Urogynecol J (2013) 1.48
Histologic comparison of pubovaginal sling graft materials: a comparative study. Urology (2008) 1.48
Clinical and demographic factors associated with valsalva leak point pressure among women undergoing burch bladder neck suspension or autologous rectus fascial sling procedures. Neurourol Urodyn (2007) 1.47
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction. Mult Scler (2013) 1.47
Identification of clinically significant prostate cancer by prostate-specific antigen screening. Arch Intern Med (2004) 1.46
The current state of surgical practice for neonatal torsion: a survey of pediatric urologists. J Pediatr Urol (2013) 1.46
Overactive bladder: evaluation and management in primary care. Cleve Clin J Med (2005) 1.45
Hypospadias and early gestation growth restriction in infants. Pediatrics (2002) 1.44
Design of the Value of Urodynamic Evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigations. Contemp Clin Trials (2009) 1.44
Implications of the FDA statement on transvaginal placement of mesh: the aftermath. Curr Urol Rep (2014) 1.42
Current controversies regarding oncologic risk associated with polypropylene midurethral slings. Curr Urol Rep (2014) 1.42
Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol (2010) 1.42
Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int (2008) 1.41
Fesoterodine dose response in subjects with overactive bladder syndrome. Urology (2008) 1.41
Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol (2015) 1.41
The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int (2009) 1.40
Placement of a transvaginal bone-anchored sling A new minimally invasive technique is useful in stress urinary incontinence. Am J Obstet Gynecol (2009) 1.39
Association between utility and treatment among patients with prostate cancer. Qual Life Res (2010) 1.39
Mixed incontinence: comparing definitions in women having stress incontinence surgery. Neurourol Urodyn (2009) 1.39